» Authors » Catherine F Slattery

Catherine F Slattery

Explore the profile of Catherine F Slattery including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 660
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Biesbroek J, Coenen M, DeCarli C, Fletcher E, Maillard P, Barkhof F, et al.
Alzheimers Dement . 2024 Mar; 20(4):2980-2989. PMID: 38477469
Introduction: White matter hyperintensities (WMH) are associated with key dementia etiologies, in particular arteriolosclerosis and amyloid pathology. We aimed to identify WMH locations associated with vascular risk or cerebral amyloid-β...
2.
Coenen M, Biessels G, DeCarli C, Fletcher E, Maillard P, Barkhof F, et al.
Neuroimage Clin . 2023 Nov; 40:103547. PMID: 38035457
Introduction: The spatial distribution of white matter hyperintensities (WMH) on MRI is often considered in the diagnostic evaluation of patients with cognitive problems. In some patients, clinicians may classify WMH...
3.
Hallqvist J, Pinto R, Heywood W, Cordey J, Foulkes A, Slattery C, et al.
Int J Mol Sci . 2023 Sep; 24(18). PMID: 37762058
As disease-modifying therapies are now available for Alzheimer's disease (AD), accessible, accurate and affordable biomarkers to support diagnosis are urgently needed. We sought to develop a mass spectrometry-based urine test...
4.
Coenen M, Kuijf H, Huenges Wajer I, Duering M, Wolters F, Fletcher E, et al.
Alzheimers Dement . 2022 Dec; 19(6):2420-2432. PMID: 36504357
Introduction: Impact of white matter hyperintensities (WMH) on cognition likely depends on lesion location, but a comprehensive map of strategic locations is lacking. We aimed to identify these locations in...
5.
Veale T, Malone I, Poole T, Parker T, Slattery C, Paterson R, et al.
Brain Commun . 2021 Dec; 3(4):fcab272. PMID: 34859218
Pathological cerebral white matter changes in Alzheimer's disease have been shown using diffusion tensor imaging. Superficial white matter changes are relatively understudied despite their importance in cortico-cortical connections. Measuring superficial...
6.
Sani T, Bond R, Marshall C, Hardy C, Russell L, Moore K, et al.
eNeurologicalSci . 2019 Dec; 17:100212. PMID: 31828228
Sleep disruption is a key clinical issue in the dementias but the sleep phenotypes of these diseases remain poorly characterised. Here we addressed this issue in a proof-of-principle study of...
7.
Canas L, Sudre C, De Vita E, Nihat A, Mok T, Slattery C, et al.
Neuroimage Clin . 2019 Nov; 24:102051. PMID: 31734530
Prion diseases are a group of rare neurodegenerative conditions characterised by a high rate of progression and highly heterogeneous phenotypes. Whilst the most common form of prion disease occurs sporadically...
8.
den Haan J, Csinscik L, Parker T, Paterson R, Slattery C, Foulkes A, et al.
Alzheimers Res Ther . 2019 Jul; 11(1):62. PMID: 31319885
Background: Retinal thickness can be measured non-invasively with optical coherence tomography (OCT) and may offer compelling potential as a biomarker for Alzheimer's disease (AD). Retinal thinning is hypothesized to be...
9.
Firth N, Primativo S, Marinescu R, Shakespeare T, Suarez-Gonzalez A, Lehmann M, et al.
Brain . 2019 Jun; 142(7):2082-2095. PMID: 31219516
Posterior cortical atrophy is a clinico-radiological syndrome characterized by progressive decline in visual processing and atrophy of posterior brain regions. With the majority of cases attributable to Alzheimer's disease and...
10.
Slattery C, Agustus J, Paterson R, McCallion O, Foulkes A, Macpherson K, et al.
Cortex . 2019 Mar; 115:357-370. PMID: 30846199
Background: Memory for music has attracted much recent interest in Alzheimer's disease but the underlying brain mechanisms have not been defined in patients directly. Here we addressed this issue in...